| DNA-repair defects and olaparib in metastatic prostate cancer J Mateo, S Carreira, S Sandhu, S Miranda, H Mossop, R Perez-Lopez, ... N Engl J Med 2015 (373), 1697-1708, 2015 | 2336 | 2015 |
| Inherited DNA-repair gene mutations in men with metastatic prostate cancer CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, ... N Engl J Med 2016 (375), 443-453, 2016 | 1658 | 2016 |
| Genomic correlates of clinical outcome in advanced prostate cancer W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ... Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019 | 1102 | 2019 |
| Mitf regulation of Dia1 controls melanoma proliferation and invasiveness S Carreira, J Goodall, L Denat, M Rodriguez, P Nuciforo, KS Hoek, ... Genes & development 20 (24), 3426-3439, 2006 | 697 | 2006 |
| Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial J Mateo, N Porta, D Bianchini, U McGovern, T Elliott, R Jones, I Syndikus, ... The Lancet Oncology 21 (1), 162-174, 2020 | 596 | 2020 |
| Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression S Carreira, J Goodall, I Aksan, SA La Rocca, MD Galibert, L Denat, ... Nature 433 (7027), 764-769, 2005 | 471 | 2005 |
| Plasma AR and abiraterone-resistant prostate cancer A Romanel, DG Tandefelt, V Conteduca, A Jayaram, N Casiraghi, ... Science translational medicine 7 (312), 312re10-312re10, 2015 | 465 | 2015 |
| Circulating cell-free DNA to guide prostate cancer treatment with PARP inhibition J Goodall, J Mateo, W Yuan, H Mossop, N Porta, S Miranda, ... Cancer discovery 7 (9), 1006-1017, 2017 | 400 | 2017 |
| Tumor clone dynamics in lethal prostate cancer S Carreira, A Romanel, J Goodall, E Grist, R Ferraldeschi, S Miranda, ... Science Translational Medicine 6 (254), 254ra125-254ra125, 2014 | 397 | 2014 |
| β-Catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development V Delmas, F Beermann, S Martinozzi, S Carreira, J Ackermann, ... Genes & development 21 (22), 2923-2935, 2007 | 378 | 2007 |
| Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer A Paschalis, B Sheehan, R Riisnaes, DN Rodrigues, B Gurel, C Bertan, ... European urology 76 (4), 469-478, 2019 | 372 | 2019 |
| Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer A Sharp, I Coleman, W Yuan, C Sprenger, D Dolling, DN Rodrigues, ... The Journal of clinical investigation 129 (1), 2018 | 361 | 2018 |
| Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100 J Richards, AC Lim, CW Hay, AE Taylor, A Wingate, K Nowakowska, ... Cancer research 72 (9), 2176-2182, 2012 | 304 | 2012 |
| Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas KW Vance, S Carreira, G Brosch, CR Goding Cancer research 65 (6), 2260-2268, 2005 | 275 | 2005 |
| The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression MD Galibert, S Carreira, CR Goding The EMBO journal 20 (17), 5022-5031, 2001 | 255 | 2001 |
| Genomics of lethal prostate cancer at diagnosis and castration resistance J Mateo, G Seed, C Bertan, P Rescigno, D Dolling, I Figueiredo, ... The Journal of clinical investigation 130 (4), 1743-1751, 2020 | 245 | 2020 |
| Brn-2 Represses Microphthalmia-Associated Transcription Factor Expression and Marks a Distinct Subpopulation of Microphthalmia-Associated Transcription Factor–Negative Melanoma … J Goodall, S Carreira, L Denat, D Kobi, I Davidson, P Nuciforo, RA Sturm, ... Cancer research 68 (19), 7788-7794, 2008 | 227 | 2008 |
| Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer DN Rodrigues, P Rescigno, D Liu, W Yuan, S Carreira, MB Lambros, ... The Journal of clinical investigation 128 (10), 4441-4453, 2018 | 218 | 2018 |
| Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration JS Frenel, S Carreira, J Goodall, D Roda, R Perez-Lopez, N Tunariu, ... Clinical Cancer Research 21 (20), 4586-4596, 2015 | 207 | 2015 |
| Tbx2 directly represses the expression of the p21WAF1 cyclin-dependent kinase inhibitor S Prince, S Carreira, KW Vance, A Abrahams, CR Goding Cancer research 64 (5), 1669-1674, 2004 | 207 | 2004 |
